Please login or register first to view this content.
Urological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Sparsentan Granted Orphan Drug Status for IgA Nephropathy
Finerenone Gets Priority Review for Diabetic Kidney Disease
Mirabegron Granted Priority Review for Neurogenic Detrusor Overactivity
Dapagliflozin Under Review for Chronic Kidney Disease
Gemtesa Approved for Overactive Bladder Treatment
FDA Requests Clarification of Data to Complete Roxadustat Review
Belimumab Approved for Lupus Nephritis
Sildenafil, Trazodone Tablets Recalled After Being Packaged Together
FDA Approves Oxlumo for Primary Hyperoxaluria Type 1
Disproportionality Signal Found for Suicidality in Finasteride Users
Finerenone NDA Submitted for Diabetic Kidney Disease
OAB Drug May Improve Outcomes in Botulinum Toxin Recipients
Novel Medication Relieves Pruritus in Hemodialysis Cases
Apabetalone Prevents CV Events in High-Risk Diabetic CKD
Finerenone Slows CKD Progression in Diabetic Kidney Disease
Glecaprevir and Pibrentasvir Aid HCV D+/R- Kidney Transplants
FDA Approves New Formulation of Ultomiris for PNH and aHUS
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
